Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13

Original Research

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

       
Total article views   HTML views PDF downloads Totals
6,483 Dovepress* 5,418+ 877 6,295
PubMed Central* 1,065 253 1,318
Totals 6,483 1,130 7,613
*Since 23 January 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar